Ocular adnexal lymphoid tumors: progress in need of clarification

Am J Ophthalmol. 2008 Jun;145(6):941-50. doi: 10.1016/j.ajo.2008.03.013. Epub 2008 Apr 11.

Abstract

Purpose: To evaluate recent ophthalmic publications on ocular adnexal lymphomas (OALs) according to histopathologic and immunophenotypic criteria used in the diagnosis of systemic lymphomas (World Health Organization classification).

Design: Summary and critical analysis of recent clinical and pathologic studies.

Methods: Literature review and interpretation.

Results: In the largest study of 353 cases of OALs published in the pathology literature, extranodal marginal zone lymphoma (EMZL) constituted 52%, follicular lymphoma 23%, mantle cell lymphoma 5%, and small cell lymphocytic and chronic lymphocytic leukemia 4%-plus a residuum of arcane entities. In smaller series of less intensively studied OALs in the ophthalmic literature, EMZLs had a higher preponderance and also were associated with a favorable prognosis. Many EMZLs seemed to arise primarily in the ocular adnexa (mucosa-associated lymphoid tissue [MALT] lymphoma should be restricted for EMZLs involving epithelial tissues).

Conclusions: Rigorous diagnostic criteria and a proposal for a prospective multicenter study may bring further clarification to the emerging order in this set of tumors.

Publication types

  • Comment
  • Review

MeSH terms

  • Conjunctival Neoplasms / pathology*
  • Eye Neoplasms / pathology*
  • Eyelid Neoplasms / pathology*
  • Humans
  • Immunophenotyping
  • Lacrimal Apparatus Diseases / pathology*
  • Lymphoma / pathology*
  • Oculomotor Muscles / pathology*